Jennifer R. Diamond, M.D. is the Chief Medical Officer of OnKure. Dr. Diamond brings expertise in early phase clinical trials and translational oncology research, in particular, first-in-human early phase clinical trials of novel therapeutics in oncology, combination strategies to potentiate the activity of immunotherapy, and new therapies for triple-negative breast cancer (TNBC). In addition to serving in her role at OnKure, Dr. Diamond works in the Division of Medical Oncology at the University of Colorado Anschutz Medical Campus as a Breast Cancer medical oncologist and Associate Professor of Medicine. She is also the Clinical Research Director of the Phase I and Expansion/Molecular Studies Program (POEMs) and the founding co-Director of the Women’s Cancer Developmental Therapeutics Program at the CU Cancer Center. Dr. Diamond has been involved in clinical and translational research in the Phase I and Breast Cancer research programs at CU since 2007 where she currently runs a research laboratory focused on the development of targeted agents in TNBC, including strategies to overcome treatment resistance.